Redox-responsive micellar drug delivery systems

This paper reviews redox-responsive drug delivery systems (DDSs) that use micelles as the nanoparticle, focusing on the systems that utilize disulfide bonds, for applications in cancer treatment. Micelles exhibit high solubility for hydrophobic drugs with slow and sustained drug release. The encapsu...

Full description

Saved in:
Bibliographic Details
Main Author: Amer, Aseel (author)
Other Authors: AlSawaftah, Nour (author), Abuwatfa, Waad H. (author), Husseini, Ghaleb (author)
Format: article
Published: 2026
Subjects:
Online Access:https://hdl.handle.net/11073/33243
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513431871160320
author Amer, Aseel
author2 AlSawaftah, Nour
Abuwatfa, Waad H.
Husseini, Ghaleb
author2_role author
author
author
author_facet Amer, Aseel
AlSawaftah, Nour
Abuwatfa, Waad H.
Husseini, Ghaleb
author_role author
dc.creator.none.fl_str_mv Amer, Aseel
AlSawaftah, Nour
Abuwatfa, Waad H.
Husseini, Ghaleb
dc.date.none.fl_str_mv 2026-03-10T08:46:13Z
2026-03-10T08:46:13Z
2026
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv Aseel Amer, Nour AlSawaftah, Waad H. Abuwatfa, Ghaleb A. Husseini, Chapter Twelve - Redox-responsive micellar drug delivery systems, Harnessing Endogenous Mechanisms for Targeted Drug Delivery, Academic Press, 2026, Pages 341-360, https://doi.org/10.1016/B978-0-443-27429-9.00007-4.
978-0-443-27429-9
https://hdl.handle.net/11073/33243
10.1016/B978-0-443-27429-9.00007-4
dc.language.none.fl_str_mv en_US
dc.publisher.none.fl_str_mv Elsevier
dc.relation.none.fl_str_mv https://doi.org/10.1016/B978-0-443-27429-9.00007-4
dc.subject.none.fl_str_mv Cancer
Encapsulated Drug
Glutathione
Micelles
Nanoparticle
Reactive Oxygen Species
dc.title.none.fl_str_mv Redox-responsive micellar drug delivery systems
dc.type.none.fl_str_mv Peer-Reviewed
Published version
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description This paper reviews redox-responsive drug delivery systems (DDSs) that use micelles as the nanoparticle, focusing on the systems that utilize disulfide bonds, for applications in cancer treatment. Micelles exhibit high solubility for hydrophobic drugs with slow and sustained drug release. The encapsulation of drugs within the micelle increases its stability. Using redox as an intrinsic trigger is possible due to the higher concentration of GSH found in cancerous cells. Several papers utilizing in vivo and in vitro studies are discussed and summarized. A redox-responsive DDS targets tumor tissues by breaking the disulfide bond when exposed to a high GSH concentration, thereby minimizing cellular side effects and drug loss. The application of redox-responsive DDSs to overcome multidrug resistance (MDR) is examined in this paper. Multistimuli DDSs are shown to have the best outcome for treating MDR.
format article
id aus_fd9bab526f320b1d8cac68ad9835fef1
identifier_str_mv Aseel Amer, Nour AlSawaftah, Waad H. Abuwatfa, Ghaleb A. Husseini, Chapter Twelve - Redox-responsive micellar drug delivery systems, Harnessing Endogenous Mechanisms for Targeted Drug Delivery, Academic Press, 2026, Pages 341-360, https://doi.org/10.1016/B978-0-443-27429-9.00007-4.
978-0-443-27429-9
10.1016/B978-0-443-27429-9.00007-4
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/33243
publishDate 2026
publisher.none.fl_str_mv Elsevier
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Redox-responsive micellar drug delivery systemsAmer, AseelAlSawaftah, NourAbuwatfa, Waad H.Husseini, GhalebCancerEncapsulated DrugGlutathioneMicellesNanoparticleReactive Oxygen SpeciesThis paper reviews redox-responsive drug delivery systems (DDSs) that use micelles as the nanoparticle, focusing on the systems that utilize disulfide bonds, for applications in cancer treatment. Micelles exhibit high solubility for hydrophobic drugs with slow and sustained drug release. The encapsulation of drugs within the micelle increases its stability. Using redox as an intrinsic trigger is possible due to the higher concentration of GSH found in cancerous cells. Several papers utilizing in vivo and in vitro studies are discussed and summarized. A redox-responsive DDS targets tumor tissues by breaking the disulfide bond when exposed to a high GSH concentration, thereby minimizing cellular side effects and drug loss. The application of redox-responsive DDSs to overcome multidrug resistance (MDR) is examined in this paper. Multistimuli DDSs are shown to have the best outcome for treating MDR.Elsevier2026-03-10T08:46:13Z2026-03-10T08:46:13Z2026Peer-ReviewedPublished versioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfAseel Amer, Nour AlSawaftah, Waad H. Abuwatfa, Ghaleb A. Husseini, Chapter Twelve - Redox-responsive micellar drug delivery systems, Harnessing Endogenous Mechanisms for Targeted Drug Delivery, Academic Press, 2026, Pages 341-360, https://doi.org/10.1016/B978-0-443-27429-9.00007-4.978-0-443-27429-9https://hdl.handle.net/11073/3324310.1016/B978-0-443-27429-9.00007-4en_UShttps://doi.org/10.1016/B978-0-443-27429-9.00007-4oai:repository.aus.edu:11073/332432026-03-11T05:27:04Z
spellingShingle Redox-responsive micellar drug delivery systems
Amer, Aseel
Cancer
Encapsulated Drug
Glutathione
Micelles
Nanoparticle
Reactive Oxygen Species
status_str publishedVersion
title Redox-responsive micellar drug delivery systems
title_full Redox-responsive micellar drug delivery systems
title_fullStr Redox-responsive micellar drug delivery systems
title_full_unstemmed Redox-responsive micellar drug delivery systems
title_short Redox-responsive micellar drug delivery systems
title_sort Redox-responsive micellar drug delivery systems
topic Cancer
Encapsulated Drug
Glutathione
Micelles
Nanoparticle
Reactive Oxygen Species
url https://hdl.handle.net/11073/33243